Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchiolitis Endotracheal Surfactant Study (BESS)
2018-001169-18Phase 2Unknown
- Sponsor
- University of Liverpool
- Start
- Aug 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of Poractant alfa in bronchiolitis, respiratory syncytial virus bronchiolitis and respiratory failure (2 arms), sponsored by University of Liverpool. Primary endpoint: Duration of mechanical ventilation. Status: unknown.
02
Drugs
Poractant alfa
03
Conditions
bronchiolitisrespiratory syncytial virus bronchiolitisrespiratory failure
Beyond the preview
Go deeper on 2018-001169-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001169-18.